Targeted pH- and redox-responsive AuS/micelles with low CMC for highly efficient sonodynamic therapy of metastatic breast cancer

Polyhexamethylene biguanidine coated silver nanoparticles embedded into chitosan thiourea/PVA nanofibers as wound healing mats: In vitro and in vivo studies

Burn injuries are prone to infection, leading to significant public health concerns and economic implications. There is a growing demand to develop innovative wound dressings with antibacterial activity. In this study, silver nanoparticles coated with polyhexamethylene biguanidine (Ag/PHMBG) were embedded into chitosan thiourea (CST) nanofibers as a novel multifunctional wound healing mat for treating second-degree burn wounds. Structural, mechanical, and biological properties of nanofibers were investigated using FE-SEM, XRD, ATR-FTIR, and In vitro degradation. The animal study was performed to investigate the suitability of the polymeric mats as a wound healing/dressing system. FE-SEM analysis revealed that the average diameter of the obtained uniform and bead-less Ag/PHMBG-loaded CST nanofibers was around 75 nm. CST-based nanofibers with 3 wt% Ag/PHMBG (PCT3) demonstrated notable antimicrobial efficacy against both S. aureus and P. aeruginosa, achieving 95 % growth inhibition within 3 days while exhibiting no cytotoxic effects on normal fibroblast cells. In addition, CST nanofibers have good breathability with a water vapor transmittance rate of 2.9 ± 0.41-4.4 ± 0.47 kg/m2. d. The animal studies showed that the wound healing and tissue regeneration process by PCT3 nanofibers were faster than the other groups. In conclusion, CST-based nanofibers are a potentially promising substitute for conventional wound dressings in clinical applications.

Synergistic effect of curcumin and Piperine loaded Niosomal nanoparticles on acute pulmonary toxicity induced by Paraquat in mice

Objective

Paraquat (PQ), a widely used non-selective herbicide, induces severe lung toxicity by promoting cell death and tissue necrosis through the generation of reactive oxygen species (ROS) and free radicals. This study aimed to develop and evaluate novel niosomal nanoparticles (NPs) encapsulating curcumin and piperine to mitigate PQ-induced acute pulmonary toxicity in Balb/c mice.

Methods

The NPs were prepared using non-ionic surfactants and cholesterol via the thin film hydration method.

Results

Characterization revealed high encapsulation efficiency (>85%), proper particle sizes (264-286 nm), narrow polydispersity index (PDI) (0.19 ± 0.04 to 0.23 ± 0.02), and good stability over 90 days. Thermal analysis confirmed successful encapsulation of curcumin and piperine within the niosomal NPs. In vivo studies showed that PQ exposure significantly elevated ROS, lipid peroxidation (LPO), and protein carbonylation (PC) levels, while reducing glutathione (GSH) levels and impairing mitochondrial function (P < 0.001). However, co-treatment with curcumin- and piperine-loaded niosomal NPs effectively reversed these effects (P < 0.001), improving mitochondrial function.

Conclusion

The combined formulation of curcumin and piperine in niosomal NPs offers a promising therapeutic strategy for treating PQ-induced pulmonary toxicity, likely due to enhanced bioavailability and potent antioxidant activity.

Novel polyurethane-based ionene nanoparticles electrostatically stabilized with hyaluronic acid for effective gene therapy

Gene therapy is considered to be a valuable strategy for effective cancer treatment. However, the development of effective delivery systems that can specifically deliver gene materials, such as siRNA to tumor tissues plays a critical role in cancer therapy. In the present study, we have developed a novel complex that is based on an electrostatic interaction between cationic polyurethane ionene (CPUI) nanoparticles and an anti-signal transducer and activator of transcription 3 (STAT3) siRNA. For active targeting, hyaluronic acid (HA) was used to coat the complexes, which significantly reduced the cytotoxicity of the blank nanocarriers while demonstrating high transport efficiency of the siRNA via the CD44-mediated endocytosis pathway in MCF-7 breast cancer cells. The targeted nanocarriers (HA/CPUI/siRNA) showed significantly higher cellular internalization in flow cytometry and confocal microscopy compared with the non-targeted system (CPUI/siRNA). In addition, the incorporation of HA on the surface of the complexes resulted in significantly greater suppression of the STAT3 gene compared to the corresponding non-targeted formulation. Whole-body fluorescence images showed more significant tumor accumulation of the targeted nanocarriers in 4T1 breast tumor-bearing mice. Therefore, HA/CPUI/siRNA nanocarriers are an interesting option for the siRNA-targeted treatment of breast cancer cells.